Eagle Global Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-27,937
Closed -$13.7M 295
2026
Q1
$13.7M Sell
27,937
-8,136
-23% -$4.42M 0.49% 50
2025
Q4
$20.9M Buy
36,073
+118
+0.3% +$66.7K 0.77% 31
2025
Q3
$17.4M Sell
35,955
-414
-1% -$193K 0.67% 36
2025
Q2
$14.7M Buy
36,369
+14,870
+69% +$6.22M 0.6% 40
2025
Q1
$10.7M Sell
21,499
-24
-0.1% -$13K 0.44% 51
2024
Q4
$11.2M Buy
21,523
+26
+0.1% +$14.3K 0.46% 50
2024
Q3
$13.3M Sell
21,497
-450
-2% -$266K 0.66% 36
2024
Q2
$12.1M Buy
21,947
+92
+0.4% +$52.7K 0.64% 39
2024
Q1
$12.7M Buy
21,855
+1,573
+8% +$883K 0.72% 40
2023
Q4
$10.8M Sell
20,282
-2,492
-11% -$1.21M 0.65% 40
2023
Q3
$11.5M Sell
22,774
-38
-0.2% -$20.2K 0.75% 34
2023
Q2
$11.9M Sell
22,812
-795
-3% -$429K 0.78% 33
2023
Q1
$13.6M Sell
23,607
-100
-0.4% -$56.4K 0.92% 31
2022
Q4
$13.1M Sell
23,707
-10,948
-32% -$5.8M 0.9% 33
2022
Q3
$17.6M Buy
34,655
+8,345
+32% +$4.67M 1.32% 20
2022
Q2
$14.3M Sell
26,310
-257
-1% -$141K 1.05% 27
2022
Q1
$15.7M Buy
26,567
+11,240
+73% +$6.46M 0.97% 29
2021
Q4
$10.2M Sell
15,327
-207
-1% -$129K 0.64% 47
2021
Q3
$8.88M Buy
15,534
+810
+6% +$445K 0.59% 52
2021
Q2
$7.43M Buy
14,724
+88
+0.6% +$41.5K 0.48% 59
2021
Q1
$6.68M Buy
+14,636
New +$6.99M 0.49% 55

Other funds holding TMO

Eagle Global Advisors's TMO Position: Q2 2026 in Review

Eagle Global Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 27,937 shares — an estimated $13.7M sold.

Eagle Global Advisors first reported a position in TMO in Q1 2021 and held it in 21 quarters. The position peaked at $20.9M in Q4 2025. 1,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Eagle Global Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Eagle Global Advisors sold 27,937 Thermo Fisher Scientific shares in Q2 2026, an estimated $13.7M.
  • Eagle Global Advisors first reported a position in Thermo Fisher Scientific in Q1 2021 and held it in 21 quarters.
  • Eagle Global Advisors's Thermo Fisher Scientific position peaked at $20.9M in Q4 2025.
  • 1,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Eagle Global Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.